Michael Hawkins

Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast Cancer

William J. Gradishar, Sergei Tjulandin, Neville Davidson et al. · Journal of Clinical Oncology · 2005 · 2.1K citations · Full text

Pharmacy, Oncology, Pharmacology +15

Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel.

Neil Desai, Vuong Trieu, Zhiwen Yao et al. · Clinical Cancer Research · 2006 · 1.2K citations

Medicine, Oncology, Pharmacology +14

Abraxane®, a novel Cremophor®-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer

M. R. Green, George Manikhas, Boris V. Afanasyev et al. · Annals of Oncology · 2006 · 647 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +13

Comparative Preclinical and Clinical Pharmacokinetics of a Cremophor-Free, Nanoparticle Albumin-Bound Paclitaxel (ABI-007) and Paclitaxel Formulated in Cremophor (Taxol)

Alex Sparreboom, Charity D. Scripture, Vuong Trieu et al. · Clinical Cancer Research · 2005 · 496 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacology +17

Interleukin-2 and lymphokine-activated killer cell therapy of solid tumors: analysis of toxicity and management guidelines.

Kim Margolin, Anthony A. Rayner, Michael Hawkins et al. · Journal of Clinical Oncology · 1989 · 349 citations

Pharmacy, Immunology, Oncology +17